Covid19

FDA restricts J&J's COVID-19 vaccine due to blood clot risk – Portland Press Herald

WASHINGTON — U.S. regulators on Thursday strictly limited who can receive Johnson & Johnson's COVID-19 vaccine due to the ongoing risk of rare but …

Read more at www.pressherald.com

Show More

Related Articles

Back to top button